GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Thermogenesis Holdings THMO · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Thermogenesis Holdings

Its shares trade under the ticker THMO. It has been listed since 5 June 1987. In the fiscal year to 31 December 2023, it reported revenue of $9.4m and a net loss of $18.0m. At that date it held total assets of $11.2m and shareholders' equity of −$3.6m.

ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. The company is headquartered in Rancho Cordova, California. The company offers a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology. Its CAR-TXpress platform is its cellular processing platform. The company offers cell manufacturing tools and services in the global cell and gene therapy market.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
5 Jun 1987
Employees
50

Leadership

Pay as last reported

  • Dr. Xiaochun XuChairman of the Board, President, Chief Executive Officer, since 2016$699,000
  • Ms. Haihong ZhuChief Operating Officer, since 2022$460,000
  • Dr. Biao XiIndependent Director$10,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • ThermoGenesis Holdings Inc employs 50 full-time employees in Rancho Cordova, California.
  • CAR-TXpress platform provides automated cell processing for cell and gene therapy.
  • Global cell and gene therapy market offers significant commercial opportunities.

Weaknesses

  • ThermoGenesis Holdings Inc has a small workforce of 50 employees.
  • The company's headquarters in Rancho Cordova, California, limits market reach.
  • Limited product portfolio compared to larger competitors in Health Care.

Opportunities

  • Growing demand for cell and gene therapy solutions in the Health Care sector.
  • Expansion into point-of-care applications for automated biobanking.
  • Increasing global market for cell manufacturing tools and services.

Threats

  • Competition from larger companies in the Health Care industry.
  • Regulatory challenges in the cell and gene therapy market.
  • Economic downturns affecting healthcare spending in the US market.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.